Resources

Publish Date
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: Hearing on USPTO Oversight
Council for Innovation Promotion
Public Comments
C4IP Comments RE: China’s Compliance With WTO Commitments (USTR-2026-0496)
Council for Innovation Promotion
Reports
C4IP Presentation RE: Revision to Rules of Practice Before the PTAB
Council for Innovation Promotion
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Hearing on Medicines and IP
Council for Innovation Promotion
Letters
C4IP Letter to the Department of Commerce and Office of Science and Technology Policy RE: the G20 Innovation Ministerial
Council for Innovation Promotion
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: USPTO Fee-Setting Authority
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Requirement to Identify All Real Parties in Interest to a Third Party Request for an Ex Parte Reexamination (PTO-P-2025-0545)
Council for Innovation Promotion
Infographics
Idea Factories Report Infographic
Council for Innovation Promotion
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on Patent Eligibility
Council for Innovation Promotion
Issue Briefs
Congress Should Pass PERA to Fix What the Supreme Court Unintentionally Broke
Council for Innovation Promotion
Public Comments
C4IP Comments RE: The Section 301 Investigation of Vietnam’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0364)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: The Section 301 Investigation of Brazil’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0331)
Council for Innovation Promotion
Resources:

Resources:

C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Resources:

Resources:

C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Resources:

Resources:

C4IP Letter to Senate HELP Committee RE: The Bayh-Dole Act and 28 U.S. Code § 1498,

03/17/2023

Resources:

Resources:

C4IP Comments RE: Joint USPTO-FDA Collaboration Initiatives (PTO-P-2022-0037),

03/10/2023

Resources:

Resources:

C4IP Comments RE: Certain Light-Based Physiological Measurement Devices and Components Thereof (337-TA-1276),

02/23/2023

Resources:

Resources:

C4IP Comments RE: Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights (PTO-P-2022-0025),

01/31/2023

Resources:

Resources:

IP, Innovation, and American Universities, Bayh-Dole Coalition,

01/15/2023

Resources:

Resources:

C4IP Letter to Secretary Becerra RE: Xtandi March-In Petition,

12/15/2022

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: The Interagency Patent Coordination and Improvement Act of 2022,

12/13/2022

Resources:

Resources:

C4IP Letter to House and Senate Judiciary Committees RE: Patent Eligibility Restoration Act,

10/13/2022

Resources:

Resources:

Intellectual property and the U.S. economy: Third edition,

03/30/2022

Resources:

Resources:

USIJ White Paper on Fintiv Doctrine,

11/29/2021

Scroll to Top